International Journal For Multidisciplinary Research

E-ISSN: 2582-2160     Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 8, Issue 2 (March-April 2026) Submit your research before last 3 days of April to publish your research paper in the issue of March-April.

Pharmaceutical Diplomacy in Asia: A Regional Architecture for Health Security, Innovation, and Strategic Autonomy

Author(s) Ms. Shefali Patnaik, Dr. Sibaram Badatya, Dr. Mahendra Pratap Swain
Country India
Abstract The concept of pharmaceutical diplomacy has a vital role to play in the realm of international relations and geopolitics as a channel between the negotiation of economic relations with regard to health security and soft power. Asia has proved that it can compete in the pharmaceutical level, with China and India together providing a substantial percentage of the overall API manufacturing at a global level, and other states with their comparative advantages further enriching the pharmaceutical picture in Asia. This development has changed Asia into a powerhouse on the global level. Nevertheless, despite such existing tangible upsides, Asian representativeness in the design of global health policy has been limited. The region's ability to act as normative authority in international health was hindered by intra and inter-state regulatory conflicts, compounded by the state. Taking a comparative approach and using qualitative case study methodology, this paper explores the patchy nature of the multisided pharmaceutical capabilities of Asian states. Through the present analysis the paper intends to establish a realistic objective of the united Asian Pharmaceutical Alliance, in conjunction with the Asian Medicines and Health Security Authority (AMSHA) sourced from a super-continental concept. This initiative would ensure the API supply chains and maintain stability by strengthening the collective bargaining power of the continent in the global health sector. Moreover, the study shows that it is critical that pharmaceutical technology is integrated into the regional collaboration framework as an integral part of the expectation of Asia’s move towards a leading pharmaceutical destination, in line with the growth within the framework of systematic development. This evolution path may place the region in a favorable pharmaceutical space for global health security, paving the way for its survival and maintenance of its strategic autonomy in the international circles and by reducing dependence on Western powers.
Keywords Pharmaceutical Diplomacy, Asian Pharmaceutical Alliance, Soft Power, Health Security, Pharma 4.0, Proposal of AMHSA, Regulatory Harmonization
Field Sociology > Politics
Published In Volume 7, Issue 5, September-October 2025
Published On 2025-10-31
DOI https://doi.org/10.36948/ijfmr.2025.v07i05.59070

Share this